SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003978
Filing Date
2015-05-12
Accepted
2015-05-11 19:03:39
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20150331.htm 10-Q 1445185
2 EX-31.1 rare-ex311_201503316.htm EX-31.1 14619
3 EX-31.2 rare-ex312_201503318.htm EX-31.2 14693
4 EX-32.1 rare-ex321_201503317.htm EX-32.1 10004
5 GRAPHIC g201505111447446122224.jpg GRAPHIC 80538
  Complete submission text file 0001564590-15-003978.txt   6210200

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rare-20150331.xml EX-101.INS 963222
7 XBRL TAXONOMY EXTENSION SCHEMA rare-20150331.xsd EX-101.SCH 34058
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20150331_cal.xml EX-101.CAL 34686
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20150331_def.xml EX-101.DEF 78764
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20150331_lab.xml EX-101.LAB 239699
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20150331_pre.xml EX-101.PRE 174550
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 15852371
SIC: 2834 Pharmaceutical Preparations